Results 231 to 240 of about 1,185,385 (293)

An impending crisis for the translational science pipeline: The dire impact of proposed NIH budget cuts on early-career researchers. [PDF]

J Clin Transl Sci
Karnik NS, Ellingrod VL, Meagher EA.
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report. [PDF]

J Venom Anim Toxins Incl Trop Dis
Ferreira RS, Mantovani CK, Ferreira ASSBS, Nascimento LO, Ferrari MFR, Kawano DF, Massirer KB, Anhê GF, Anholon R, Caricati CP, Ortega LM, Guilbert S, Lambe T, Oliveira-Filho JP, Clemens SAC, Barraviera B.   +15 more
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

An iterative approach to evaluating impact of CTSA projects using the translational science benefits model. [PDF]

Front Health Serv
Swanson K, Stadnick NA, Bouchard I, Du Z, Brookman-Frazee L, Aarons GA, Treichler E, Gholami M, Rabin BA.   +8 more
europepmc   +1 more source

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, EarlyView.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

Environment scan of generative AI infrastructure for clinical and translational science. [PDF]

Npj Health Syst
Idnay B, Xu Z, Adams WG, Adibuzzaman M, Anderson NR, Bahroos N, Bell DS, Bumgardner C, Campion T, Castro M, Cimino JJ, Cohen IG, Dorr D, Elkin PL, Fan JW, Ferris T, Foran DJ, Hanauer D, Hogarth M, Huang K, Kalpathy-Cramer J, Kandpal M, Karnik NS, Katoch A, Lai AM, Lambert CG, Li L, Lindsell C, Liu J, Lu Z, Luo Y, McGarvey P, Mendonca EA, Mirhaji P, Murphy S, Osborne JD, Paschalidis IC, Harris PA, Prior F, Shaheen NJ, Shara N, Sim I, Tachinardi U, Waitman LR, Wright RJ, Zai AH, Zheng K, Lee SS, Malin BA, Natarajan K, Price Ii WN, Zhang R, Zhang Y, Xu H, Bian J, Weng C, Peng Y.   +56 more
europepmc   +1 more source

Academic influencers: Clinical and Translational Science scholars and trainees at the intersection of influential scholarship and public attention. [PDF]

J Clin Transl Sci
Nehl EJ, Pelfrey CM, DiazGranados D, Dave G, Llewellyn NM.   +4 more
europepmc   +1 more source

Building an evaluation infrastructure to capture process and progress within a Clinical and Translational Science Awards hub. [PDF]

J Clin Transl Sci
Padek M, Mudaranthakam DP, Pepper S, Penne Mays M, Ellis SD.   +4 more
europepmc   +1 more source